Bank Of America Corp Rhythm Pharmaceuticals, Inc. Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

A detailed history of Bank Of America Corp transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 106,250 shares of RYTM stock, worth $6.01 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

106,250

Previous 92,043 15.44%

Holding current value

$6.01 Million

Previous $3.78 Million 47.29%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$40.81 - $55.0 $579,787 - $781,385	14,207 Added 15.44%	106,250 $5.57 Million
Q2 2024 Aug 14, 2024	SELL	$35.41 - $44.37 $675,304 - $846,180	-19,071 Reduced 17.16%	92,043 $3.78 Million
Q1 2024 May 15, 2024	BUY	$39.12 - $52.44 $1.61 Million - $2.16 Million	41,244 Added 59.03%	111,114 $4.81 Million
Q4 2023 Feb 14, 2024	SELL	$21.39 - $49.64 $1.5 Million - $3.49 Million	-70,248 Reduced 50.13%	69,870 $3.21 Million
Q2 2023 Aug 14, 2023	SELL	$16.32 - $21.15 $3.58 Million - $4.64 Million	-219,548 Reduced 61.04%	140,118 $2.31 Million
Q1 2023 May 12, 2023	BUY	$16.88 - $34.24 $1.58 Million - $3.2 Million	93,513 Added 35.14%	359,666 $6.42 Million
Q4 2022 Feb 10, 2023	BUY	$22.21 - $30.25 $1.06 Million - $1.44 Million	47,744 Added 21.86%	266,153 $7.75 Million
Q3 2022 Nov 14, 2022	BUY	$4.3 - $30.85 $727,977 - $5.22 Million	169,297 Added 344.72%	218,409 $5.35 Million
Q2 2022 Aug 12, 2022	BUY	$3.12 - $12.25 $29,630 - $116,338	9,497 Added 23.97%	49,112 $203,000
Q1 2022 May 16, 2022	SELL	$6.13 - $12.24 $508,912 - $1.02 Million	-83,020 Reduced 67.7%	39,615 $457,000
Q4 2021 Feb 08, 2022	SELL	$8.62 - $13.9 $705,357 - $1.14 Million	-81,828 Reduced 40.02%	122,635 $1.22 Million
Q3 2021 Nov 15, 2021	BUY	$11.68 - $20.72 $990,288 - $1.76 Million	84,785 Added 70.84%	204,463 $2.67 Million
Q2 2021 Sep 13, 2021	BUY	$18.52 - $22.55 $2.22 Million - $2.7 Million	119,678 New	119,678 $2.34 Million

Others Institutions Holding RYTM

# of Institutions

191

Shares Held

67.3M

Call Options Held

834K

Put Options Held

78.6K

View Full List

About RHYTHM PHARMACEUTICALS, INC.

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.15B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

More about RYTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Rhythm Pharmaceuticals, Inc. Transaction History